Show results for
  • Sygnature
  • News
  • Drug Discovery
  • Therapeutic Areas
  • Events
  • Vacancies

Categories for... Drug Discovery

Drug Discovery

Sygnature Discovery delivers clinical candidate to Corcept Therapeutics

READ ARTICLE

Drug Discovery

Discovery of orally-available, potent and selective plasma kallikrein inhibitors for the treatment of diabetic macular edema with KalVista Pharmaceuticals

READ ARTICLE